Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia

Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli

(2011) Yi-Lin Cheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates

(2011) Yang Yang et al.   BIOMATERIALS

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

(2011) W.-C. Chou et al.   BLOOD

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

(2011) C-L Cheng et al.   BRITISH JOURNAL OF CANCER

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

(2011) M. Yamamoto-Sugitani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information

(2010) W.- C. Chou et al.   ANNALS OF ONCOLOGY

WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system

(2010) H.-A. Hou et al.   BLOOD

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation

(2010) W. C. Chou et al.   BLOOD

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

(2010) W.-C. Chou et al.   BLOOD

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

(2010) M. J. Streetly et al.   BLOOD

Expression Profile of Galectin-1 and Galectin-3 Molecules in Different Subtypes of Chronic Lymphocytic Leukemia

(2010) Hossein Asgarian-Omran et al.   CANCER INVESTIGATION

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

(2010) Anna I. Markowska et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Prognostic value of galectin-3 in primary cutaneous melanoma

(2010) M. Buljan et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

(2010) W-C Chou et al.   LEUKEMIA

Galectin-3 expression is associated with bladder cancer progression and clinical outcome

(2010) Giacomo Canesin et al.   TUMOR BIOLOGY

Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas

(2009) Seok Jin Kim et al.   ACTA HAEMATOLOGICA

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations

(2009) J.-L. Tang et al.   BLOOD

Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis

(2008) Avraham Raz et al.   Anti-Cancer Agents in Medicinal Chemistry

Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas

(2008) Nicky D’Haene et al.   BRITISH JOURNAL OF HAEMATOLOGY

Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma

(2008) Yasunori Matsuda et al.   HEPATOLOGY RESEARCH

Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

(2008) Peter Paschka et al.   JOURNAL OF CLINICAL ONCOLOGY

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival

(2008) Axel S. Merseburger et al.   WORLD JOURNAL OF UROLOGY

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

(2007) Hsin-An Hou et al.   LEUKEMIA RESEARCH